Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 146

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 146
---
 outstanding. If all of the 2,100,000 shares of our Common Stock offered for resale by the Selling Securityholder under this prospectus were issued and outstanding as of May 19, 2025, such shares would represent approximately 8.2% of total number of shares of our fully-diluted Common Stock outstanding. The actual number of shares of our Common Stock issuable will vary depending on the then current market price of shares of our Common Stock sold to the Selling Securityholder in this offering. The number of shares of Common Stock ultimately offered for sale by the Selling Securityholder for resale under this prospectus is dependent upon the number of shares of Common Stock, if any, we ultimately sell to Keystone under the Keystone Purchase Agreements. Further, if and when we elect to sell shares of Common Stock to Keystone pursuant to the Keystone Purchase Agreements, after Keystone has acquired such shares, Keystone may resell all, some or none of such shares of Common Stock at any time or from time to time in its discretion and at different prices. The issuance of our shares of Common Stock to the Selling Securityholder pursuant to the Purchase Agreements will not affect the rights or privileges of our existing stockholders, except that the economic and voting interests of each of our existing stockholders will be diluted. Although the number of shares of Common Stock that our existing stockholders own will not decrease, the shares of Common Stock owned by our existing stockholders will represent a smaller percentage of our total outstanding shares of Common Stock after any such issuance. Although the Keystone Purchase Agreements provides that we may sell up to an aggregate of $25.0 million of our shares of our Common Stock to Keystone, we have only registered an aggregate of 2,100,000 shares of Common Stock for resale under the Registration Statements, including 2,086,357 Keystone Purchase Shares pursuant to the registration statement of which this prospectus forms a part. If it becomes necessary for us to issue and sell more shares than are being registered for resale under the Registration Statements in order to receive aggregate gross proceeds equal to $25.0 million under the Keystone Purchase Agreements, we must first file with the SEC one or more additional registration statements to register under the Securities Act the resale by Keystone of any such additional shares of our Common Stock we wish to sell from time to time under the Keystone Purchase Agreements, which the SEC must declare effective, in each case, before we may elect to sell any additional shares of our Common Stock to Keystone under the Keystone Purchase Agreements.